Skip to content
My Media
My Playlists
Login
My Media
My Playlists
Login
Home
Live Broadcasts
All Recordings
Archived
Employees
Wellness
Fitness and Movement
Healthy Eating
Wellness Tips Tools and Resources
Grand Rounds
Advanced Practice Providers
Center for Genomic Medicine
Dartmouth Cancer Center
Dermatology
Heart and Vascular Center
HIV and AIDS Seminars
Informatics
Leadership Preventative Medicine
Medicine
Neurology
Nursing
OB/GYN
Orthopaedics
Pediatric
Primary Care and Population Health
Psychiatry Grand Rounds
Surgery
Value Grand Rounds
Healthcare Professionals
AIM / ERASEMM Webinars
DHC/CHaD Pediatric Webinars
Nursing Education
Research
Office of Research Operations
PI Forum
Translational Tuesday
Live Broadcasts
Patients
Special Events
Home
Live Broadcasts
All Recordings
Archived
Employees
Wellness
Fitness and Movement
Healthy Eating
Wellness Tips Tools and Resources
Grand Rounds
Advanced Practice Providers
Center for Genomic Medicine
Dartmouth Cancer Center
Dermatology
Heart and Vascular Center
HIV and AIDS Seminars
Informatics
Leadership Preventative Medicine
Medicine
Neurology
Nursing
OB/GYN
Orthopaedics
Pediatric
Primary Care and Population Health
Psychiatry Grand Rounds
Surgery
Value Grand Rounds
Healthcare Professionals
AIM / ERASEMM Webinars
DHC/CHaD Pediatric Webinars
Nursing Education
Research
Office of Research Operations
PI Forum
Translational Tuesday
Live Broadcasts
Patients
Special Events
In silico antibody discovery @ EMD Serono
From
Web Engineering
views
Related Media
Details
Back
Biomedical Data Science Grand Rounds February 28, 2019 Yves Fomekong Nanfack, Ph.D. Director at EMD Serono, a division of Merck KGaA
Tags